Share

ARMYDA CRP

ARMYDA CRP - Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty C reactive Protein

Project objectives

Evaluation of the prognostic role of inflammatory markers (C-Reactive Protein) and platelet aggregation indices on short- and long-term outcomes in patients undergoing percutaneous coronary revascularization.

Start and end date

May 2012 - ongoing

Project Manager

Dr. Giuseppe Patti - Principal Investigator

Prof. Germano Di Sciascio - Principal Investigator

Coordinating institution of the project

Università Campus Bio-Medico di Roma

QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right